Medication comparison to reduce bleeding in planned C-section for placenta previa
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study compares two medications, tranexamic acid and vasopressin, given during a planned C-section to reduce bleeding. The goal is to find the safer and more effective option for women with placenta previa.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old
- You are pregnant with one baby (not twins or more)
- You have been diagnosed with placenta previa in this pregnancy
- Your C-section is planned (not an emergency)
- You do not have bleeding or clotting problems, and you are not on blood-thinning or anti-platelet medicines
- You have no history of severe bleeding after childbirth, no chronic liver or kidney disease, no gestational diabetes, and no pregnancy-related high blood pressure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether tranexamic acid can prevent heavy bleeding after a planned or urgent cesarean delivery in people with placenta previa. If you qualify, you may receive the study drug to help your body keep blood loss lower during and after surgery.
This study tests whether giving tranexamic acid, a medicine that helps blood clot, before a cesarean section can reduce blood loss during and after the surgery. It may help women who are at higher risk of bleeding during delivery.
This trial tests whether giving a drug called tranexamic acid before a planned C-section can reduce the risk of severe bleeding after birth. It is for women who are otherwise healthy and expecting a single baby.
This trial tests whether giving a medicine called tranexamic acid before a cesarean section (c-section) can help reduce the amount of blood loss during the surgery. It may be an option for women having either a planned or unplanned c-section.
This trial studies whether tranexamic acid, a medicine that helps blood clot, can prevent postpartum hemorrhage (heavy bleeding after delivery) in people having a planned C-section or likely vaginal delivery after 34 weeks. It may help lower the risk of dangerous bleeding around the time of birth.
This study tests whether giving tranexamic acid during a repeat cesarean section can reduce blood loss and prevent heavy bleeding. It may help if you are having a second or third c-section and are considered low risk for bleeding problems.
Hear when a new Placenta Previa trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.